We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-5.85%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.2B
AUM Growth
-$3.94B
Cap. Flow
-$1.12B
Cap. Flow %
-3.19%
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$63.8M
2
ALGN icon
Align Technology
ALGN
+$61.4M
3
STLA icon
Stellantis
STLA
+$54.4M
4
UBS icon
UBS Group
UBS
+$49.7M
5
RSG icon
Republic Services
RSG
+$44M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$73.1M
2
IPGP icon
IPG Photonics
IPGP
+$62.1M
3
ADBE icon
Adobe
ADBE
+$61.1M
4
UNH icon
UnitedHealth
UNH
+$56.3M
5
AAPL icon
Apple
AAPL
+$54.5M

Sector Composition

Rank Sector Weight
1 Technology 29.78%
2 Healthcare 17.08%
3 Financials 11.22%
4 Consumer Discretionary 10.87%
5 Industrials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEN
101
DELISTED
ZENDESK INC
ZEN
$82M 0.23%
681,570
-567
-0.1% -$61.6K
NOVT icon
102
Novanta
NOVT
$4.91B
$81.5M 0.23%
572,741
+392
+0.1% +$55.6K
VRTX icon
103
Vertex Pharmaceuticals
VRTX
$124B
$80.3M 0.23%
307,619
-98,580
-24% -$23.4M
BLK icon
104
Blackrock
BLK
$170B
$79.1M 0.22%
103,531
-9,714
-9% -$7.59M
COF icon
105
Capital One
COF
$129B
$78.9M 0.22%
600,926
+120,908
+25% +$17.6M
TENB icon
106
Tenable Holdings
TENB
$3.51B
$78.8M 0.22%
1,363,261
+87,614
+7% +$4.53M
DRE
107
DELISTED
Duke Realty Corp.
DRE
$78.7M 0.22%
1,355,969
-78,819
-5% -$4.46M
ECL icon
108
Ecolab
ECL
$78.8B
$78.6M 0.22%
445,309
-241,222
-35% -$45.3M
GM icon
109
General Motors
GM
$81.7B
$78.6M 0.22%
1,797,521
+347,592
+24% +$17.4M
ADM icon
110
Archer Daniels Midland
ADM
$39.1B
$78.4M 0.22%
868,288
-25,363
-3% -$1.98M
DIS icon
111
Walt Disney
DIS
$171B
$78.3M 0.22%
570,954
+21,732
+4% +$3.14M
CMCSA icon
112
Comcast
CMCSA
$87.7B
$78.1M 0.22%
1,668,068
+287,145
+21% +$13.8M
DAR icon
113
Darling Ingredients
DAR
$9.33B
$77.4M 0.22%
963,494
+74,911
+8% +$5.22M
ROP icon
114
Roper Technologies
ROP
$40.4B
$76.8M 0.22%
162,681
-36,314
-18% -$16.3M
ABMD
115
DELISTED
Abiomed Inc
ABMD
$75.8M 0.22%
228,896
+2,434
+1% +$749K
HDB icon
116
HDFC Bank
HDB
$123B
$75.3M 0.21%
2,456,394
+164,310
+7% +$5.34M
BAC icon
117
Bank of America
BAC
$434B
$73M 0.21%
1,770,351
-41,463
-2% -$1.87M
EL icon
118
Estee Lauder
EL
$30.8B
$72.9M 0.21%
267,709
-16,375
-6% -$4.93M
K
119
DELISTED
Kellanova
K
$71.7M 0.2%
1,184,618
+15,589
+1% +$937K
TEL icon
120
TE Connectivity
TEL
$60B
$71.6M 0.2%
546,708
-157,992
-22% -$22.6M
HOLX
121
DELISTED
Hologic
HOLX
$71.4M 0.2%
929,819
+220,135
+31% +$15.8M
AVB icon
122
AvalonBay Communities
AVB
$27.5B
$71M 0.2%
285,758
+3,996
+1% +$976K
INTU icon
123
Intuit
INTU
$91.1B
$70.9M 0.2%
147,452
-90,024
-38% -$46.1M
SNPS icon
124
Synopsys
SNPS
$73.5B
$70.4M 0.2%
211,154
+80,567
+62% +$25.1M
EXPD icon
125
Expeditors International
EXPD
$22.3B
$69.9M 0.2%
677,161
-151,261
-18% -$16.7M

Similar funds

Axa's Q1 2022 Portfolio in Review

As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Freshpet worth $30.3M.

  • Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
  • Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
  • Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
  • Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
  • Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
  • Axa opened 111 new positions and closed 94 in Q1 2022.
  • Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.